There are now several experimental treatments vying to be tested, but each must be greenlit by national regulatory authorities whenever and wherever an outbreak occurs. There remain deeply divergent positions among scientists about how to design outbreak trials, specifically whether studies that don’t compare treatments to placebos can generate useful data

Quick Read

China is making a bid to use its Ebola vaccine in the Democratic Republic of the Congo. It’s a move that could further complicate efforts to test a crowded field of vaccines and therapies in the context of a waning outbreak

Quick Read

The infection, an emerging threat, has killed virtually all of its victims so far in India

Quick Read

Although there is optimism that the Ebola outbreak in central Africa can still be quickly contained, the fight is already becoming more complex, health experts said this week

Quick Read

A deep understanding of the Congo’s culture and time-honored public-health tactics are the keys to controlling the outbreak

Quick Read

A campaign to vaccinate people at risk of developing Ebola in the latest outbreak in the Democratic Republic of the Congo could begin by the end of this week, Tedros Adhanom Ghebreyesus, the director-general of the World Health Organization, said Sunday

Quick Read

Members of a government ethics panel have renewed their criticisms of a controversial study in which volunteers are to be deliberately infected with the Zika virus

Quick Read

The World Health Organization (WHO) in Geneva, Switzerland, put the brakes on implementation of the world’s first dengue vaccine today when it recommended it only be used in people who have previously been infected with the disease—a move that will shrink the potential market for the vaccine’s producer, Sanofi Pasteur

Quick Read